Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 11, 2001, Pages 1315-1318

  Doweck, Ilana ^a,b,c   Thomas Robbins, K ^a,b   Vieira, Francisco ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RECURRENCE; FOLLOW UP; HEAD CANCER; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NECK CANCER; RISK FACTOR; TUMOR LOCALIZATION;

EID: 17944378056     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.127.11.1315     Document Type: Article

References (16)

1. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.
2. Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck: report of the Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23:705-713.
3. Lefebvre J-L, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer. J Natl Cancer Inst. 1996;88:890-899.
4. El Sarraf M, LeBlanc M, Shanker Giri PG, et al. Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup Study 0099. J Clin Oncol. 1998;16:1310-1317.
5. Bobbins KT, Fontanesi J, Wong FSH, et al. A novel organ preservation protocol for advanced carcinoma of the larynx and the pharynx. Arch Otolaryngol Head Neck Surg. 1996;122:853-857.
6. Bobbins KT. The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000;126:265-269.
7. Bobbins KT, Wong FSH, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125:670-675.
8. Bobbins KT, Vicario D, Seagren S, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg. 1994;18:419-422.
9. Kumar P, Wan J, Viera F, Wong FSH, Bobbins KT. The prophylactic use of pentoxifylline in the therapy of stage IV-N2-3 head and neck squamous cell carcinoma treated with supradose intra-arterial targeted cisplatin and concurrent radiation therapy: preliminary results of a pilot study [abstract). Int J Radiat Oncol Biol Phys. 1999;45(3, suppl):279. Abstract 1044.
10. Kotwall C, Sako K, Bazack MS, Bao U, Bakamjian V, Shedd DP. Metastatic pattern in squamous cell cancer of the head and neck. Am J Surg. 1987;154:439-442.
11. Zbaren P, Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma: an analysis of 101 cases at autopsy. Arch Otolaryngol Head Neck Surg. 1987;113:762-764.
12. Dennington ML, Carter DR, Meyers AD. Distant metastases in head and neck epidermoid carcinoma. Laryngoscope. 1980;90:196-201.
13. Vikram B, Strong E, Shah J, Spiro B. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck. 1984;6:730-733.
14. Nishijima W, Takooda S, Tokita N, Takayama S, Sakura M. Analysis of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg. 1993;119:65-68.
15. Alvi A, Johnson JT. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck. 1997;19:500-505.
16. Samant S, Kumar P, Wan J, et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck. 1999;21:595-601.